Atman Shah to Risk Factors
This is a "connection" page, showing publications Atman Shah has written about Risk Factors.
Connection Strength
0.449
-
Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study. Cardiovasc Revasc Med. 2026 05; 86:1-9.
Score: 0.104
-
Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2019 Dec 01; 94(7):1028-1033.
Score: 0.070
-
Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
Score: 0.053
-
Physicians ... wake up! JACC Cardiovasc Interv. 2008 Dec; 1(6):689-91.
Score: 0.033
-
1-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Postapproval Study. JACC Cardiovasc Interv. 2026 05 11; 19(9):1139-1151.
Score: 0.027
-
Early U.S. Real-World Experience With a Novel Intra-Annular Self-Expanding Valve for Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2026 04 13; 19(7):801-809.
Score: 0.027
-
Comparative Outcomes of Intracardiac vs Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: Insights From EMERGE LAA Postapproval Study. JACC Cardiovasc Interv. 2025 12 22; 18(24):3055-3068.
Score: 0.026
-
Lipid-lowering therapy in patients with peripheral arterial disease. J Cardiovasc Pharmacol Ther. 2004 Dec; 9(4):271-7.
Score: 0.025
-
Concomitant Lower-Extremity Deep Vein Thrombosis in Patients With Pulmonary Embolism Undergoing Catheter-Directed Therapy. J Invasive Cardiol. 2021 11; 33(11):E910-E915.
Score: 0.020
-
Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system. Catheter Cardiovasc Interv. 2019 06 01; 93(7):1228-1235.
Score: 0.016
-
Electronic cardiac arrest triage score best predicts mortality after intervention in patients with massive and submassive pulmonary embolism. Catheter Cardiovasc Interv. 2018 08 01; 92(2):366-371.
Score: 0.016
-
The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. JACC Cardiovasc Interv. 2017 12 11; 10(23):2349-2359.
Score: 0.015
-
Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):272-8.
Score: 0.009
-
Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. J Invasive Cardiol. 2008 Jun; 20(6):292-5.
Score: 0.008